Leading the way to safer medication
 Crosscheck  Recommender

Tripotassium dicitrato bismuthate

Therapeutic Indications

Tripotassium dicitrato bismuthate is indicated for:

Gastric ulcer, duodenal ulcer

Irrespective of gender only Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 1200 mg in 4 divided doses daily


Active ingredient Tripotassium dicitrato bismuthate is contraindicated in the following cases:

Severe renal insufficiency

No gender/age discrimination

The administration of tripotassium dicitrato bismuthate is contraindicated in severe renal insufficiency.